Divert to ULTRA: differences in infused volumes and clearance in two on-line hemodiafiltration treatments

Int J Artif Organs. 2012 Jun;35(6):435-43. doi: 10.5301/ijao.5000106.

Abstract

Background: Mixed diffusive-convective dialysis therapies offer greater removal capabilities than conventional dialysis. The aim of this study was to compare two different on-line, post-dilution hemodiafiltration (HDF) treatments with regard to achieved convective volume and middle-molecule dialysis efficiency: standard volume control (sOL-HDF) and automated control of the transmembrane pressure (TMP) (UC-HDF).

Methods: We enrolled 30 ESRD patients (55.9 ± 14.0 years, 20/10 M/F) in a randomized, prospective, cross-over study. The patients received a 3-month period of sOL-HDF followed by UC-HDF for a further 3 months, or vice versa, using the same dialysis machine. In sOL-HDF, fixed exchange volumes were set according to a filtration fraction greater than or equal to 25%. In UC-HDF therapy, the exchanged volume was driven by a biofeedback system controlling the TMP and its set point in a double loop. Patients maintained their treatment time, dialyzer, blood flow rate, and anticoagulant regimen unchanged throughout the study.

Results: Greater convective volumes were achieved in UC-HDF than in sOL-HDF (23.8 ± 3.9 vs.19.8 ± 4.8 L; p<0.001) with high pre-dialysis Ht value (sOL-HDF 34.0 ± 4.5% and UC-HDF 34.0 ± 4.4%; p = 0.91). The average clearance values of ß2m and P were higher in UC-HDF than in sOL-HDF (respectively 123 ± 24 vs. 111 ± 22 ml/min, p<0.002 and 158 ± 26 vs. 152 ± 25 ml/min, p<0.05). Moreover, the UC-HDF mode led to a significantly increased rate of call-free sessions from 88% to 97% (p<0.0001).

Conclusions: This study showed that the biofeedback module, applied to the automatic control of TMP in on-line HDF, results in higher convective volumes and correspondingly higher ß2m and P clearances. By making the HDF treatment more automated and less complex to perform, it significantly reduced the staff workload.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anticoagulants / therapeutic use
  • Automation
  • Biomarkers / blood
  • Cross-Over Studies
  • Equipment Design
  • Feedback
  • Female
  • Hemodiafiltration / instrumentation
  • Hemodiafiltration / methods*
  • Hemodiafiltration / nursing
  • Humans
  • Italy
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / nursing
  • Kidney Failure, Chronic / therapy*
  • Male
  • Membranes, Artificial
  • Middle Aged
  • Phosphates / blood
  • Pressure
  • Prospective Studies
  • Time Factors
  • Treatment Outcome
  • Workload
  • beta 2-Microglobulin / blood

Substances

  • Anticoagulants
  • Biomarkers
  • Membranes, Artificial
  • Phosphates
  • beta 2-Microglobulin